Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockDiscover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q4 FY26
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Jeena Sikho Lifecare Ltd (JSLL) is currently trading at 617.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Jeena Sikho Lifecare Limited is an integrated Ayurvedic healthcare company operating a dual model of hospitals/clinics (services) and an OTC/personal care products business, running a hub‑and‑spoke network across 23 states with 58 hospitals, 59 clinics/day‑care centres and several thousand beds operational and in development. Q3 FY26 performance shows sharp operational momentum: Revenue at ₹221.7 crore (▲92% YoY, ▲17% QoQ), EBITDA ₹100.8 crore with a 45% margin and PAT ₹66.7 crore at a 30% margin, highlighting unusually high profitability for a healthcare chain driven by product margins and operating leverage in services. The company’s business model is capital‑light: management reports per‑bed set‑up costs of ₹3–4 lakh, 35/117 facilities run by franchisees, and a stated 71% 3‑year ROCE, enabling fast scalability while preserving a relatively robust balance sheet and low reported borrowings historically. Products and services are roughly parity contributors to recent revenue (about 49% services, 51% products for 9MFY26) with product gross margins near ~85%, providing strong cash generation that funds service expansion and supports rapid OTC rollouts via new distribution tie‑ups like Entero. Strategic growth levers include an international push (UAE, Kazakhstan, Nepal), a diagnostics partnership with Chandan, a planned Jeena Sikho Health Card for customer loyalty, and a target long‑term ambition of 7,000–10,000 beds alongside an accelerated OTC product roadmap.
Over the past 52 weeks, Jeena Sikho Lifecare Ltd has traded between a low of ₹491.95 and a high of ₹850.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Jeena Sikho Lifecare Ltd has a market capitalization of approximately 7,372.28. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Jeena Sikho Lifecare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 33.24 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 7,372.28 Cr, Jeena Sikho Lifecare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Jeena Sikho Lifecare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Jeena Sikho Lifecare Ltd is 33.24. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
499.30 | 8,646 Cr | 34.89 | 6.36 | 0.24 | 18.22 | 24.16 | 15.10 | ||
725.40 | 8,235 Cr | 47.63 | 9.32 | 0.21 | 19.57 | 22.16 | 14.83 | ||
3142.00 | 8,112 Cr | 19.63 | 9.43 | 3.49 | 42.11 | 52.41 | 25.64 | ||
936.15 | 7,534 Cr | 36.03 | 6.29 | 0.11 | 17.46 | 23.00 | 15.41 | ||
594.30 | 7,372 Cr | 33.24 | 15.78 | 0.76 | 47.50 | 52.11 | 32.88 | ||
204.00 | 6,620 Cr | 4.26 | 4.94 | 0.00 | 116.01 | 80.89 | 71.55 | ||
378.25 | 6,158 Cr | 21.88 | 2.48 | 1.32 | 11.32 | 15.18 | 9.64 | ||
| Median: 7 Co. | — | 594.30 | 7,534 Cr | 33.24 | 6.36 | 0.24 | 19.57 | 24.16 | 15.41 |
Bearish
6
Neutral
6
Bullish
2
Bearish
28
Neutral
6
Bullish
12
Bearish
22
Neutral
0
Bullish
10
Jeena Sikho Lifecare Limited is an integrated Ayurvedic healthcare company operating a dual model of hospitals/clinics (services) and an OTC/personal care products business, running a hub‑and‑spoke network across 23 states with 58 hospitals, 59 clinics/day‑care centres and several thousand beds operational and in development.
Q3 FY26 performance shows sharp operational momentum: Revenue at ₹221.7 crore (▲92% YoY, ▲17% QoQ), EBITDA ₹100.8 crore with a 45% margin and PAT ₹66.7 crore at a 30% margin, highlighting unusually high profitability for a healthcare chain driven by product margins and operating leverage in services.
The company’s business model is capital‑light: management reports per‑bed set‑up costs of ₹3–4 lakh, 35/117 facilities run by franchisees, and a stated 71% 3‑year ROCE, enabling fast scalability while preserving a relatively robust balance sheet and low reported borrowings historically.
Products and services are roughly parity contributors to recent revenue (about 49% services, 51% products for 9MFY26) with product gross margins near ~85%, providing strong cash generation that funds service expansion and supports rapid OTC rollouts via new distribution tie‑ups like Entero.
Strategic growth levers include an international push (UAE, Kazakhstan, Nepal), a diagnostics partnership with Chandan, a planned Jeena Sikho Health Card for customer loyalty, and a target long‑term ambition of 7,000–10,000 beds alongside an accelerated OTC product roadmap.
Pharmaceuticals & Biotechnology
Pharmaceuticals
7,669 Cr
High Risk
34.6
34.1
2.1
15.8
850.00
491.95
Sales CAGR
Profit CAGR
ROE
ROCE
New Hospital Facility
Jeena Sikho Lifecare plans a new 160+ bed hospital at Singh Palace, Kanpur Road, Lucknow (≈1.25 lakh sq.ft.), targeted to commence Aug 2026 with an estimated investment of ~Rs.3 crore funded from internal resources.
Commencement of Operations
Jeena Sikho Lifecare commenced operations of Sanskriti Ayurvedic P.G. Medical College & Hospital in Semri, Mathura (U.P.) from June 10, 2026 — a ~60,000 sq ft, 100‑bed facility with 8 OPD.
Hospital Opening
Jeena Sikho Lifecare Ltd. commenced operations of Sanskriti Ayurvedic P.G. Medical College & Hospital in Semri, Mathura (UP) effective June 10, 2026 — 100 beds, ~60,000 sq.ft, 8 OPD units.
Earnings Transcript
Jeena Sikho Lifecare filed the transcript of its Q4 and FY26 earnings conference call (held June 2, 2026) discussing audited results for year ended Mar 31, 2026; transcript is available on the company website.
Earnings Call Transcript
Jeena Sikho submitted the transcript of its Q4 & FY26 earnings conference call discussing audited results — FY26 revenue INR801cr (+71%), EBITDA INR349cr (44% margin), PAT INR222cr (28%), net debt-free and growth plans.
